Donor Stem Cell Transplantation Associated With Survival Benefit For Patients With Leukemia
Thursday, June 18, 2009 - 23:28
in Health & Medicine
An analysis of previous studies indicates that allogeneic stem cell transplantation (SCT -- stem cells from a compatible donor) is associated with significant overall and relapse-free survival benefit among adult patients with intermediate- and poor-risk but not good-risk acute myeloid leukemia in first complete remission, compared with nonallogeneic SCT therapies.
Read the whole article on Science Daily
More from Science Daily
Related
- Donor stem cell transplantation associated with survival benefit for patients with leukemiaTue, 9 Jun 2009, 16:45:18 EDT
- Study IDs benefit of donor SCT for adults with acute myeloid leukemiaTue, 9 Jun 2009, 16:45:12 EDT
- Leukemia stem cells have more in common with embryonic stem cells than adult stem cellsThu, 5 Feb 2009, 12:45:38 EST
- Data presented demonstrate prolonged overall survival for patients with acute myeloid leukemiaWed, 10 Dec 2008, 17:39:36 EST
- Toronto researcher's discovery points to a new treatment avenue for acute myeloid leukemiaMon, 6 Jul 2009, 11:29:24 EDT